PMID: 9653141Jul 8, 1998Paper

Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation

Proceedings of the National Academy of Sciences of the United States of America
J Jin, S P Kunapuli

Abstract

ADP is an important platelet agonist causing shape change and aggregation required for physiological hemostasis. We recently demonstrated the existence of two distinct G protein-coupled ADP receptors on platelets, one coupled to phospholipase C, P2Y1, and the other to inhibition of adenylyl cyclase, P2TAC. In this study, using specific antagonists for these two receptors, we demonstrated that concomitant intracellular signaling from both the P2TAC and P2Y1 receptors is essential for ADP-induced platelet aggregation. Inhibition of signaling through either receptor, by specific antagonists, is sufficient to block ADP-induced platelet aggregation. Furthermore, signaling through the P2TAC receptor could be replaced by activation of alpha2A-adrenergic receptors. On the other hand, activation of serotonin receptors supplements signaling through the P2Y1 receptor. Moreover, this mechanism of ADP-induced platelet aggregation could be mimicked by coactivation of two non-ADP receptors coupled to Gi and Gq, neither of which can cause platelet aggregation by itself. We propose that platelet aggregation results from concomitant signaling from both the Gi and Gq, a mechanism by which G protein-coupled receptors elicit a physiological response.

References

Jan 1, 1992·Annual Review of Physiology·J Pouysségur, K Seuwen
Apr 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·D C MillsR W Colman
Feb 17, 1972·The New England Journal of Medicine·E W Salzman
Sep 5, 1995·Biochemical and Biophysical Research Communications·G van WilligenJ W Akkerman
Jun 1, 1995·Trends in Pharmacological Sciences·R G HumphriesP Leff
Jun 2, 1995·The Journal of Biological Chemistry·W H Moolenaar
Oct 1, 1994·The Journal of Clinical Investigation·T HirataS Narumiya
Apr 1, 1994·Trends in Pharmacological Sciences·S M Hourani, D A Hall
Apr 1, 1993·The Journal of Cell Biology·V J LaMorteJ R Feramisco
Feb 9, 1996·The Journal of Biological Chemistry·A B MacKenzieS O Sage
Aug 2, 1996·The Journal of Biological Chemistry·G K AkbarS P Kunapuli
May 1, 1996·British Journal of Pharmacology·J B SchachterT K Harden
Oct 18, 1996·The Journal of Biological Chemistry·S OffermannsM I Simon
Mar 1, 1997·Trends in Pharmacological Sciences·B B FredholmM Williams
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·J GabbetaA K Rao
Sep 20, 1997·Nature·S OffermannsM I Simon
Jan 24, 1998·The Journal of Biological Chemistry·D CommuniJ M Boeynaems
Mar 14, 1998·FEBS Letters·P SaviJ M Herbert

❮ Previous
Next ❯

Citations

Apr 25, 2000·Biochemical and Biophysical Research Communications·I M FrancischettiC Bon
Mar 28, 2008·Purinergic Signalling·David Erlinge, Geoffrey Burnstock
Jun 29, 2011·Purinergic Signalling·Stephen O'ConnorJean-Philippe Collet
Jul 28, 2011·Purinergic Signalling·Béatrice Hechler, Christian Gachet
Oct 12, 2012·International Journal of Hematology·Fatemeh Moheimani, Denise E Jackson
Jan 12, 2013·Journal of Cardiovascular Translational Research·Giovanni Cimmino, Paolo Golino
Jul 4, 2006·Biochemical Pharmacology·Ranieri RossiAldo Milzani
Mar 19, 2004·Bioorganic & Medicinal Chemistry·Romain MathieuJean-Jacques Bourguignon
Jun 16, 2005·Pharmacology & Therapeutics·Christian Gachet
Jun 1, 2005·Thrombosis Research·Sven NylanderTomas L Lindahl
Feb 13, 2001·European Journal of Pharmacology·A BaurandC Gachet
Jul 8, 1999·European Journal of Pharmacology·S TakanoT Ono
Mar 6, 2003·Atherosclerosis·Nicolas von BeckerathAdnan Kastrati
Jun 28, 2000·Journal of the Autonomic Nervous System·N J Cusack, S M Hourani
Apr 17, 2002·Cellular Signalling·Alison W GagnonRobert J Leadley
Jan 22, 2004·Critical Reviews in Oncology/hematology·Indra Ramasamy
Oct 30, 2008·Nature Clinical Practice. Cardiovascular Medicine·Nina C RajuJack Hirsh
Feb 29, 2000·British Journal of Pharmacology·G E JarvisP Leff
Jan 30, 2002·British Journal of Pharmacology·Catherine VialRichard J Evans
Oct 19, 2001·European Journal of Biochemistry·B T AtkinsonS P Watson
Apr 12, 2000·European Journal of Biochemistry·C DangelmaierS P Kunapuli
Apr 16, 2009·The Journal of Biological Chemistry·Jesica R WilliamsYuko Fujiwara
Apr 15, 2011·The Journal of Biological Chemistry·Amanda J UnsworthCatherine J Pears
Aug 30, 2008·The Journal of Biological Chemistry·Gianni F GuidettiMauro Torti
Mar 17, 2009·The Journal of Biological Chemistry·Yamini S BynagariSatya P Kunapuli
Dec 2, 2009·European Heart Journal·Dominick J AngiolilloShinya Goto
Oct 18, 2001·Current Opinion in Hematology·B SavageZ M Ruggeri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.